Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xiu Wu, Hongmin Liang, Yan Tang, Daiwen Chen, Bing Yu, Jun He, Xiangbing Mao, Zhiqing Huang, Hui Yan, Aimin Wu, Yuheng Luo, Ping Zheng, Jie Yu, Junning Pu & Junqiu Luo. (2023) Dietary ferulic acid supplementation improves antioxidant capacity and lipid metabolism in liver of piglets with intrauterine growth retardation. Animal Biotechnology 0:0, pages 1-10.
Read now
Read now
Daniel A. Enquobahrie, Sixto E. Sanchez, Martin Muy-Rivera, Chunfang Qiu, Cuilin Zhang, Melissa A. Austin & Michelle A. Williams. (2005) Hepatic lipase gene polymorphism, pre-pregnancy overweight status and risk of preeclampsia among Peruvian women. Gynecological Endocrinology 21:4, pages 211-217.
Read now
Read now
Birgit Wetzka, Michael M. Hoffmann, Isolde Friedrich, Manfred W. Baumstark, Hans Peter Zahradnik, Winfried März & Karl Winkler. (2004) Transient Remnant Removal Disease in Acute Fatty Liver of Pregnancy. Hypertension in Pregnancy 23:2, pages 143-153.
Read now
Read now
Articles from other publishers (67)
Xin Zhang, Yang Yun, Zheng Lai, Shuli Ji, Ge Yu, Zechen Xie, Hao Zhang, Xiang Zhong, Tian Wang & Lili Zhang. (2023) Supplemental Clostridium butyricum modulates lipid metabolism by reshaping the gut microbiota composition and bile acid profile in IUGR suckling piglets. Journal of Animal Science and Biotechnology 14:1.
Crossref
Crossref
Ya-Fei Chen, Xing-Chen Wang, Zhe Wang, Le Chen, Xi-Wei Liu, Xin-Yi Song, Jing-Wen Zhang, Chuan-Li Wang, Yang-Yang Guo & Jin-Hui Xu. (2023) ANTIGRAVIDADE SIMULADA LEVOU À TRANSFORMAÇÃO DO METABOLISMO DE GLICOLIPÍDIOS NO FÍGADO DE CAMUNDONGOS. Revista Brasileira de Medicina do Esporte 29.
Crossref
Crossref
Ya-Fei Chen, Xing-Chen Wang, Zhe Wang, Le Chen, Xi-Wei Liu, Xin-Yi Song, Jing-Wen Zhang, Chuan-Li Wang, Yang-Yang Guo & Jin-Hui Xu. (2023) SIMULATED WEIGHTLESSNESS LED TO THE TRANSFORMATION OF GLYCOLIPID METABOLISM IN THE LIVERS OF MICE. Revista Brasileira de Medicina do Esporte 29.
Crossref
Crossref
Carles Foguet, Yu Xu, Scott C. Ritchie, Samuel A. Lambert, Elodie Persyn, Artika P. Nath, Emma E. Davenport, David J. Roberts, Dirk S. Paul, Emanuele Di Angelantonio, John Danesh, Adam S. Butterworth, Christopher Yau & Michael Inouye. (2022) Genetically personalised organ-specific metabolic models in health and disease. Nature Communications 13:1.
Crossref
Crossref
Niina Sandholm, Ronja Hotakainen, Jani K. Haukka, Fanny Jansson Sigfrids, Emma H. Dahlström, Anni A. Antikainen, Erkka Valo, Anna Syreeni, Elina Kilpeläinen, Anastasia Kytölä, Aarno Palotie, Valma Harjutsalo, Carol Forsblom & Per-Henrik Groop. (2022) Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations. Genome Medicine 14:1.
Crossref
Crossref
Karl Otfried Schwab & Jürgen DoerferKarl Otfried Schwab & Jürgen Doerfer. 2022. Pädiatrische Fettstoffwechselstörungen und Atheroskleroserisiko – kompakt. Pädiatrische Fettstoffwechselstörungen und Atheroskleroserisiko – kompakt
43
140
.
Masami Shimizu-Albergine, Debapriya Basu, Jenny E. Kanter, Farah Kramer, Vishal Kothari, Shelley Barnhart, Carissa Thornock, Adam E. Mullick, Noemie Clouet-Foraison, Tomas Vaisar, Jay W. Heinecke, Robert A. Hegele, Ira J. Goldberg & Karin E. Bornfeldt. (2021) CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins. Journal of Clinical Investigation 131:22.
Crossref
Crossref
Tasnia Sharin, Kim L. Williams, Suzanne Chiu, Doug Crump & Jason M. O'Brien. (2021) Toxicity Screening of Bisphenol A Replacement Compounds: Cytotoxicity and mRNA Expression in Primary Hepatocytes of Chicken and Double‐Crested Cormorant. Environmental Toxicology and Chemistry 40:5, pages 1368-1378.
Crossref
Crossref
Ryutaro Matsumoto, Katsuhiko Tsunekawa, Yoshifumi Shoho, Yoshimaro Yanagawa, Nobuo Kotajima, Shingo Matsumoto, Osamu Araki, Takao Kimura, Katsuyuki Nakajima & Masami Murakami. (2019) Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men. Lipids in Health and Disease 18:1.
Crossref
Crossref
Jesús E. Millán Núñez-Cortes & Joaquín J. Millán Pérez. 2019. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
275
281
.
Kiyomi Nakajima, Tetsuo Machida, Shigeyuki Imamura, Daisuke Kawase, Kazuya Miyashita, Isamu Fukamachi, Masahiro Maeda, Yuji Muraba, Takafumi Koga, Junji Kobayashi, Takao Kimura, Katsuyuki Nakajima & Masami Murakami. (2018) An automated method for measuring lipoprotein lipase and hepatic triglyceride lipase activities in post-heparin plasma. Clinica Chimica Acta 487, pages 54-59.
Crossref
Crossref
Guillaume Paré, Shihong Mao & Wei Q. Deng. (2018) A robust method to estimate regional polygenic correlation under misspecified linkage disequilibrium structure. Genetic Epidemiology 42:7, pages 636-647.
Crossref
Crossref
Yuji Muraba, Takafumi Koga, Yohnosuke Shimomura, Yasuki Ito, Yuko Hirao, Junji Kobayashi, Takao Kimura, Katsuyuki Nakajima & Masami Murakami. (2018) The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease. Clinica Chimica Acta 476, pages 146-153.
Crossref
Crossref
Kazuya Miyashita, Katsuyuki Nakajima, Isamu Fukamachi, Yuji Muraba, Takafumi Koga, Yohnosuke Shimomura, Tetsuyo Machida, Masami Murakami & Junji Kobayashi. (2017) A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase. Journal of Lipid Research 58:8, pages 1591-1597.
Crossref
Crossref
I. Ramasamy. (2016) Update on the molecular biology of dyslipidemias. Clinica Chimica Acta 454, pages 143-185.
Crossref
Crossref
Junji Kobayashi, Kazuya MiyashitaKatsuyuki Nakajima & Hiroshi Mabuchi. (2015) Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism. Journal of Atherosclerosis and Thrombosis 22:10, pages 1001-1011.
Crossref
Crossref
Jessica Sparks Lilley, MacRae F. Linton & Sergio Fazio. 2015. Dyslipidemias. Dyslipidemias
221
233
.
Alexander Bartelt, F. Timo Beil, Brigitte Müller, Till Koehne, Timur A. Yorgan, Markus Heine, Tayfun Yilmaz, Wolfgang Rüther, Joerg Heeren, Thorsten Schinke & Andreas Niemeier. (2014) Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity. Bone 62, pages 90-98.
Crossref
Crossref
Andrew J. Juren, Gautamn Sarwal, Ahmad Al-Sarraf, Michal Vrablik, Darren Chan, Karin H. Humphries & Jiri J. Frohlich. (2013) Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol. Journal of Clinical Lipidology 7:3, pages 194-198.
Crossref
Crossref
Stephen G. Young & Rudolf Zechner. (2013) Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes & Development 27:5, pages 459-484.
Crossref
Crossref
J. Tentor, R.T. Nakamura, M. Gidlund, S. Barros-Mazon, L.M. Harada, V.S. Zago, J.F. Oba & E.C. de Faria. (2012) Association of postalimentary lipemia with atherosclerotic manifestations. Brazilian Journal of Medical and Biological Research 45:11, pages 1086-1094.
Crossref
Crossref
Paolla F.C. Ferreira, Vanessa H.S. Zago, Fabio L. D'Alexandri, Natália B. Panzoldo, Magnus A. Gidlund, Rui T. Nakamura, Roberto Schreiber, Eliane S. Parra, Fernanda D. Santiago, Edna R. Nakandakare, Eder C.R. Quintão & Eliana C. de Faria. (2012) Oxidized low-density lipoproteins and their antibodies: Relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases. Clinica Chimica Acta 413:19-20, pages 1472-1478.
Crossref
Crossref
Abdelali Tali, Amal Addebbous, Laila Zougaghi & Laila Chabaa. (2012) Pathogénie, intérêts diagnostique et pronostique de l’hypertriglycéridémie dans les lymphohistiocytoses hémophagocytaires. Revue Francophone des Laboratoires 2012:444, pages 75-78.
Crossref
Crossref
Muhammad Jasim Uddin, Do Ngoc Duy, Mehmet Ulas Cinar, Dawit Tesfaye, Ernst Tholen, Heinz Juengst, Christian Looft & Karl Schellander. (2011) Detection of quantitative trait loci affecting serum cholesterol, LDL, HDL, and triglyceride in pigs. BMC Genetics 12:1.
Crossref
Crossref
Cynthia Chatterjee & Daniel L. Sparks. (2011) Hepatic Lipase, High Density Lipoproteins, and Hypertriglyceridemia. The American Journal of Pathology 178:4, pages 1429-1433.
Crossref
Crossref
James Soh, Joby Josekutty & M. Mahmood Hussain. 2011. Henry's Clinical Diagnosis and Management by Laboratory Methods. Henry's Clinical Diagnosis and Management by Laboratory Methods
226
248
.
Robert J. BrownWilliam R. LagorSandhya SankaranaravananTomoyuki YasudaThomas QuertermousGeorge H. RothblatDaniel J. Rader. (2010) Impact of Combined Deficiency of Hepatic Lipase and Endothelial Lipase on the Metabolism of Both High-Density Lipoproteins and Apolipoprotein B–Containing Lipoproteins. Circulation Research 107:3, pages 357-364.
Crossref
Crossref
Daphna Weissglas-Volkov & Päivi Pajukanta. (2010) Genetic causes of high and low serum HDL-cholesterol. Journal of Lipid Research 51:8, pages 2032-2057.
Crossref
Crossref
Tetsuya Nakamura, Rie Kerakawati & Tetsuo Morita. (2010) Prazosin Stimulates the Release of Hepatic Triacylglycerole Lipase Caused from Primary-culture Rat Hepatocytes. JOURNAL OF HEALTH SCIENCE 56:4, pages 462-466.
Crossref
Crossref
Eirini M. Tsompanidi, Maria S. Brinkmeier, Elisavet H. Fotiadou, Smaragda M. Giakoumi & Kyriakos E. Kypreos. (2010) HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis. Atherosclerosis 208:1, pages 3-9.
Crossref
Crossref
Ernst J. Schaefer. 2010. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease
1
14
.
Mandy van Hoek, Geesje M Dallinga-Thie, Ewout W Steyerberg & Eric J G Sijbrands. (2009) Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes. European Journal of Human Genetics 17:11, pages 1386-1393.
Crossref
Crossref
Anne K Soutar. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Carlos Stocco. 2009. Reproductive Endocrinology. Reproductive Endocrinology
291
312
.
Hanaa Zidan, Stanley Lo, Donald Wiebe, Julie Talano & Ramin Alemzadeh. (2008) Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft‐versus‐host disease of the liver. Pediatric Blood & Cancer 50:6, pages 1280-1281.
Crossref
Crossref
Takeyoshi Murano, Tomokazu Oyama, Yoh Miyashita & Kohji Shirai. (2008) A Case of Obstructive Jaundice with Severe Hypercholesterolemia Probably Due to Lipoprotein-Y. Journal of Atherosclerosis and Thrombosis 15:5, pages 276-280.
Crossref
Crossref
Jacques Genest, Zari Dastani, James C. Engert & Michel Marcil. 2007. High‐Density Lipoproteins. High‐Density Lipoproteins
465
490
.
Brian G. Kral & Diane M. Becker. (2007) Familial occurrence of abnormalities of high-density lipoprotein cholesterol. Journal of Clinical Lipidology 1:1, pages 31-40.
Crossref
Crossref
Lita Freeman, Marcelo J.A. Amar, Robert Shamburek, Beverly Paigen, H. Bryan BrewerJr.Jr., Silvia Santamarina-Fojo & Herminia González-Navarro. (2007) Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice. Journal of Lipid Research 48:1, pages 104-113.
Crossref
Crossref
Clive R. Pullinger & John P. Kane. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Zari Dastani, James C Engert, Jacques Genest & Michel Marcil. (2006) Genetics of high-density lipoproteins. Current Opinion in Cardiology 21:4, pages 329-335.
Crossref
Crossref
Atif Qasim & Daniel J. Rader. (2006) Human genetics of variation in high-density lipoprotein cholesterol. Current Atherosclerosis Reports 8:3, pages 198-205.
Crossref
Crossref
Sharon L. KarackattuBernardo TrigattiMonty Krieger. (2006) Hepatic Lipase Deficiency Delays Atherosclerosis, Myocardial Infarction, and Cardiac Dysfunction and Extends Lifespan in SR-BI/Apolipoprotein E Double Knockout Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 26:3, pages 548-554.
Crossref
Crossref
Danielle DuffyDaniel J. Rader. (2006) Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport. Circulation 113:8, pages 1140-1150.
Crossref
Crossref
Hisashi Tagashira, Rie Kerakawati, Toshio Motoyashiki & Tetsuo Morita. (2006) Involvement of Leukotriene Production in Release of Hepatic Lipase Activity Produced by Heparin from Rat Hepatocytes. JOURNAL OF HEALTH SCIENCE 52:1, pages 85-90.
Crossref
Crossref
Yoshihiro Inamoto, Tamio Teramoto, Koji Shirai, Hideko Tsukamoto, Takaomi Sanda, Koichi Miyamura, Ikuo Yamamori, Noriyuki Hirabayashi & Yoshihisa Kodera. (2005) Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation. International Journal of Hematology 82:4, pages 362-366.
Crossref
Crossref
Gary F. LewisDaniel J. Rader. (2005) New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport. Circulation Research 96:12, pages 1221-1232.
Crossref
Crossref
Isabelle L. Ruel, Patrick Couture, Jeffrey S. Cohn & Benoît Lamarche. (2005) Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency. Atherosclerosis 180:2, pages 355-366.
Crossref
Crossref
A Turchin, D A Wiebe, E W Seely, T Graham, W Longo & R Soiffer. (2004) Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver. Bone Marrow Transplantation 35:1, pages 85-89.
Crossref
Crossref
I. Bjarnason, F. Bissoli, A. Conforti, L. Maiden, N. Moore, U. Moretti, K.D. Rainsford, K. Takeuchi & G.P. Velo. 2005. Nimesulide — Actions and Uses. Nimesulide — Actions and Uses
315
415
.
Silvia Santamarina-FojoHerminia González-NavarroLita FreemanElke WagnerZengxuan Nong. (2004) Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 24:10, pages 1750-1754.
Crossref
Crossref
Herminia González-Navarro, Zengxuan Nong, Marcelo J.A. Amar, Robert D. Shamburek, Jamila Najib-Fruchart, Beverly J. Paigen, H. Bryan BrewerJr.Jr. & Silvia Santamarina-Fojo. (2004) The Ligand-binding Function of Hepatic Lipase Modulates the Development of Atherosclerosis in Transgenic Mice. Journal of Biological Chemistry 279:44, pages 45312-45321.
Crossref
Crossref
Hans Jansen. (2004) Hepatic lipase: Friend or foe and under what circumstances?. Current Atherosclerosis Reports 6:5, pages 343-347.
Crossref
Crossref
Marju Tilly-Kiesi, Ernst J Schaefer, Petteri Knudsen, Francine K Welty, Gregory G Dolnikowski, Marja-Riitta Taskinen & Alice H Lichtenstein. (2004) Lipoprotein metabolism in subjects with hepatic lipase deficiency. Metabolism 53:4, pages 520-525.
Crossref
Crossref
Poupak Farahani, Janis S. Fisler, Howard Wong, Adam L. Diament, Nengjun Yi & Craig H. Warden. (2012) Reciprocal Hemizygosity Analysis of Mouse Hepatic Lipase Reveals Influence on Obesity. Obesity Research 12:2, pages 292-305.
Crossref
Crossref
E Shyong Tai, Chee Eng Tan, Dolores Corella, Mabel Deurenberg-Yap, Jeffery Cutter, Suok Kai Chew & Jose M. Ordovas. (2003) Dietary Fat Interacts with the −514C>T Polymorphism in the Hepatic Lipase Gene Promoter on Plasma Lipid Profiles in a Multiethnic Asian Population: The 1998 Singapore National Health Survey. The Journal of Nutrition 133:11, pages 3399-3408.
Crossref
Crossref
Marina CuchelDaniel J. Rader. (2003) Genetics of Increased HDL Cholesterol Levels. Arteriosclerosis, Thrombosis, and Vascular Biology 23:10, pages 1710-1712.
Crossref
Crossref
Kevin E. Yarasheski, Pablo Tebas, Sherry Claxton, Donna Marin, Trey Coleman, William G. Powderly & Clay F. Semenkovich. (2003) Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia. American Journal of Physiology-Endocrinology and Metabolism 285:4, pages E899-E905.
Crossref
Crossref
Zhiguang Su, Sizhong Zhang, Daniel W. Nebert, Li Zhang, Dejia Huang, Yiping Hou, Linchuan Liao & Cuiying Xiao. (2002) A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity. Journal of Lipid Research 43:10, pages 1595-1601.
Crossref
Crossref
Hans Jansen, Adrie J.M. Verhoeven & Eric J.G. Sijbrands. (2002) Hepatic lipase. Journal of Lipid Research 43:9, pages 1352-1362.
Crossref
Crossref
Dmitri Sviridov & Paul Nestel. (2002) Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161:2, pages 245-254.
Crossref
Crossref
Elena Bravo, Alfredo Cantafora, Michael Avella & Kathleen M. Botham. (2016) Metabolism of Chylomicron Cholesterol is Delayed by Estrogen. An In Vivo Study in the Rat. Experimental Biology and Medicine 226:2, pages 112-118.
Crossref
Crossref
Arnold von EckardsteinJerzy-Roch NoferGerd Assmann. (2001) High Density Lipoproteins and Arteriosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 21:1, pages 13-27.
Crossref
Crossref
Grace Zlaket-Matta, B. Sylvia Vela & Eliot A. Brinton. (2001) The Clinical Relevance and Management of High-Density Lipoprotein Deficiency. The Endocrinologist 11:1, pages 16-25.
Crossref
Crossref
Arnold von Eckardstein, Jerzy-Roch Nofer & Gerd Assmann. (2000) Acceleration of reverse cholesterol transport. Current Opinion in Cardiology 15:5, pages 348-354.
Crossref
Crossref
E.N. Kort, D.G. Ballinger, W. Ding, S.C. Hunt, B.R. Bowen, V. Abkevich, K. Bulka, B. Campbell, C. Capener, A. Gutin, K. Harshman, M. McDermott, T. Thorne, H. Wang, B. Wardell, J. Wong, P.N. Hopkins, M. Skolnick & M. Samuels. (2000) Evidence of Linkage of Familial Hypoalphalipoproteinemia to a Novel Locus on Chromosome 11q23. The American Journal of Human Genetics 66:6, pages 1845-1856.
Crossref
Crossref
Kerry-Anne Rye, Moira A. Clay & Philip J. Barter. (1999) Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145:2, pages 227-238.
Crossref
Crossref